Study S001721

Efficacy of Vildagliptin, Liraglutide and Empagliflozin in the Management of Fatty Liver Disease Among Patients With Type 2 Diabetes

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT05041673
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: NONE
Status: UNKNOWN
Enrollment: 120
Start: 2021-02-23
Primary completion: 2021-09-30
Lead sponsor: Alexandria University
Conditions: Fatty Liver, Nonalcoholic; Diabetes Mellitus, Type 2
Interventions: DRUG:Metformin
Results posted: FALSE
Individual participant data sharing: YES

Registered primary outcomes

Change in steatosis as measured using CAP score (fibroscan) and MRI [12 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.